FDA Labels Kratom Products ‘Opioids’

The FDA is heightening warning that kratom products present safety hazards and are prone to abuse.

Kratom / Image: Shutterstock
Kratom / Image: Shutterstock

According to a recent Forbes article, FDA Commissioner Scott Gottleib released a statement urging people who are self-medicating with kratom to seek help from healthcare professionals to find pain relievers that are approved by the FDA. Kratom is a medicinal herb taken to combat chronic pain, anxiety, and depression; it’s typically sold over the counter and comes in the form of a pill or tea.

Gottlieb’s statement says that kratom contains naturally occurring chemicals that register as opioids on unpublished computer models. The FDA is quick to point out that no scientific studies support the therapeutic use of kratom, but the agency has collected 44 fatal adverse reaction reports where kratom was present in the bodies of the deceased. The scientific community has known about kratom’s opioid characteristics since 1996, but it has sat in regulatory limbo since it makes no specific disease treatment claims.

List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report